Read + Share
Muller-Miny L, Heming M, Lautwein T, Ruck T, et al. Alemtuzumab treatment exemplifies discordant immune effects of blood and
cerebrospinal fluid in multiple sclerosis. J Neuroimmunol 2023;378:578088.
PMID: 37062182
|
 |
|
Muller-Miny L, Heming M, Lautwein T, Ruck T, et al. Alemtuzumab treatment exemplifies discordant immune effects of blood and
cerebrospinal fluid in multiple sclerosis. J Neuroimmunol 2023;378:578088.
PMID: 37062182
|
|
|
|